Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Omegacuff

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Enrolling By Invitation1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT04793035Not ApplicableCompletedPrimary

Omega Cuff for GERD Feasibility Study

NCT07707011Not ApplicableEnrolling By InvitationPrimary

Potassium Competitive Acid Blocker (PCAB) Test-Guided vs Physiologic Test-Guided Treatment in Patients With Typical Reflux Symptoms

Showing all 2 trials

Research Network

Common Treatments

  • Omegacuff1
  • Pcabtest Guided1

Active Sponsors

  • Aplos Medical1
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
  • Mahidol University1
  • National Institutes of Health (NIH)1

Top Investigators

Activity Timeline